English

    Overview

  • Dr. Rahul Roy Chowdhury is a highly experienced Consultant in Gynaecology and Gynaecological Oncology at Manipal Hospitals, Saltlake, Kolkata. With 33 years of distinguished experience, including 19 years as a specialist, he is widely recognised for his unparalleled expertise in the field of Gynaecological Oncology.

  • He completed his MBBS from the University of Calcutta before moving to the United Kingdom, where he spent a significant part of his career. There, he underwent rigorous training across several renowned institutions and earned the prestigious FRCOG qualification from the Royal College of Obstetricians and Gynaecologists, London. He also holds a Certificate of Completion of Training (CCT) from the Professional Medical Education and Training Board in the UK and is a member of the Royal College of Obstetricians and Gynaecologists (MRCOG).

  • Dr. Roy Chowdhury further specialised in Gynaecological Oncology at the esteemed Oxford Cancer Centre, at a renowned Hospital. After returning to India, he quickly established himself as one of the leading experts in the field. He is known for his exceptional proficiency in complex gynaecologic oncological surgeries, including pelvic and upper abdominal procedures, peritonectomies, and radical pelvic floor clearances for ovarian and cervical cancers. He is also skilled in laparoscopic pelvic and retroperitoneal nodal clearances for endometrial cancers, sentinel lymph node biopsies, and surgeries for vulvar cancer.

  • As a clinician-scientist, he has participated in both sponsored and investigator-initiated clinical trials, contributing to practice-changing research in advanced cervical cancer. He has also been invited as a resource faculty at a Medical College, where he trained consultants in gynaecologic oncologic surgery and conducted multidisciplinary tumour boards.

  • With his extensive experience, advanced international training, and commitment to delivering personalised, high-quality care, Dr. Roy Chowdhury is regarded as one of the foremost specialists in Gynaecological Oncology in Kolkata. Dedicated to advancing women’s health through expertise, compassion, and innovation always.

    • Field of Expertise

  • Expertise in performing Gynaecologic Oncological Surgeries, such as Pelvic and Upper Abdominal Surgeries, Peritonectomies, and Radical Pelvic Floor Clearances in ovarian and cervical cancers, improving the lives of these patients.
  • Skilled in Minimally Invasive Laparoscopic Procedures such as Laparoscopic Pelvic and Retroperitoneal Nodal Clearances for the treatment of endometrial cancers.
  • Experienced in performing Vulvar Cancer surgeries and providing specialised care for patients.

    • Fellowship & Membership

  • Fellow of the Royal College of Obstetricians and Gynaecologists, UK (FRCOG)
  • Member of the Royal College of Obstetricians and Gynaecologists, UK (MRCOG)
  • Member of the Association of Gynaecologic Oncology
  • Member of the Gynae Cancer InterGroup
  • Founding member of the Kolkata Gynecological Oncology Trials and Translational Research Group

    • Languages Spoken

  • English
  • Bengali
  • Hindi

    • Awards & Achievements

  • Local Mentor for In-Country IGCS Fellowship, India.
  • LMIC representative for the 1st Endometrial Cancer Consensus Conference for Clinical Research (ECCC-CR) on November 2nd and 3rd, 2023, in Seoul, Korea.
  • Resource person for training consultants at Chittagong Medical College, Chittagong, Bangladesh [Invited by Medical Education and Health Manpower Development, Directorate General of Medical Education, Dhaka].

    • Talks & Publications

  • Ghosh DD, Chowdhury R R, Dutta R, Mukhopadhyay I, Mukhopadhyay A, Roychoudhury S. In-silico analysis of TCGA data showing multiple POLE-like favourable subgroups overlapping with TP53 mutated endometrial cancer: Implications for clinical practice in low and middle-income countries. https://doi.org/10.1016/j.gore.2023.101209.
  • Mandal P, Bhattacharjee B, Sen S, Bhattacharya A, Saha SS, Chowdhury RR, Mondal NR, Chakrabarty B, Chatterjee T, Roy S, Sengupta S. Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes. Transl Oncol. 2021 Oct 27;15(1):101256. doi: 10.1016/j.tranon.2021.101256. Epub ahead of print. PMID: 34717279; PMCID: PMC8564679.
  • Kurtz JE, Gebski V, Sukhin V, Carey M, Kong I, Glasspool RM, Berek JS, de Paiva Batista M, Hall M, Kim JW, Yeoshoua E, Fujiwara N, Nam BH, Polleis S, Lee JY, Strojna A, Farrelly L, Schwameis R, Fossati R, Darlington AS, Lai CH, Wright AA, Rosenblat O, Harter P, Roxburgh P, Chowdhury RR, Chang TC, Paoletti X, Friedlander M; Gynecologic Cancer InterGroup (GCIG) symptom benefit committee. Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee. Gynecol Oncol. 2021 May;161(2):502-507. doi: 10.1016/j.ygyno.2021.02.018. Epub 2021 Feb 19. PMID: 33612336.
  • Mukhopadhyay A, Ghosh T, Bhattacharjee D, Chakraborty D, Gupta , Roychowdhury I, Chatterjee P, Vemekar M, Chowdhury RR, Intermittent PARP Inhibitor Regimen In Ovarian Cancer (IPIROC): Origin and Feasibility Of Implementing A Proof –Of –Concept Exploratory Study.18 October 2023 IGCS Abstracts.

    Fellowship & Membership

  • Fellow of the Royal College of Obstetricians and Gynaecologists, UK (FRCOG)
  • Member of the Royal College of Obstetricians and Gynaecologists, UK (MRCOG)
  • Member of the Association of Gynaecologic Oncology
  • Member of the Gynae Cancer InterGroup
  • Founding member of the Kolkata Gynecological Oncology Trials and Translational Research Group

    • Overview

  • Dr. Rahul Roy Chowdhury is a highly experienced Consultant in Gynaecology and Gynaecological Oncology at Manipal Hospitals, Saltlake, Kolkata. With 33 years of distinguished experience, including 19 years as a specialist, he is widely recognised for his unparalleled expertise in the field of Gynaecological Oncology.

  • He completed his MBBS from the University of Calcutta before moving to the United Kingdom, where he spent a significant part of his career. There, he underwent rigorous training across several renowned institutions and earned the prestigious FRCOG qualification from the Royal College of Obstetricians and Gynaecologists, London. He also holds a Certificate of Completion of Training (CCT) from the Professional Medical Education and Training Board in the UK and is a member of the Royal College of Obstetricians and Gynaecologists (MRCOG).

  • Dr. Roy Chowdhury further specialised in Gynaecological Oncology at the esteemed Oxford Cancer Centre, at a renowned Hospital. After returning to India, he quickly established himself as one of the leading experts in the field. He is known for his exceptional proficiency in complex gynaecologic oncological surgeries, including pelvic and upper abdominal procedures, peritonectomies, and radical pelvic floor clearances for ovarian and cervical cancers. He is also skilled in laparoscopic pelvic and retroperitoneal nodal clearances for endometrial cancers, sentinel lymph node biopsies, and surgeries for vulvar cancer.

  • As a clinician-scientist, he has participated in both sponsored and investigator-initiated clinical trials, contributing to practice-changing research in advanced cervical cancer. He has also been invited as a resource faculty at a Medical College, where he trained consultants in gynaecologic oncologic surgery and conducted multidisciplinary tumour boards.

  • With his extensive experience, advanced international training, and commitment to delivering personalised, high-quality care, Dr. Roy Chowdhury is regarded as one of the foremost specialists in Gynaecological Oncology in Kolkata. Dedicated to advancing women’s health through expertise, compassion, and innovation always.

    • Field of Expertise

  • Expertise in performing Gynaecologic Oncological Surgeries, such as Pelvic and Upper Abdominal Surgeries, Peritonectomies, and Radical Pelvic Floor Clearances in ovarian and cervical cancers, improving the lives of these patients.
  • Skilled in Minimally Invasive Laparoscopic Procedures such as Laparoscopic Pelvic and Retroperitoneal Nodal Clearances for the treatment of endometrial cancers.
  • Experienced in performing Vulvar Cancer surgeries and providing specialised care for patients.

    • Languages Spoken

  • English
  • Bengali
  • Hindi

    • Awards & Achievements

  • Local Mentor for In-Country IGCS Fellowship, India.
  • LMIC representative for the 1st Endometrial Cancer Consensus Conference for Clinical Research (ECCC-CR) on November 2nd and 3rd, 2023, in Seoul, Korea.
  • Resource person for training consultants at Chittagong Medical College, Chittagong, Bangladesh [Invited by Medical Education and Health Manpower Development, Directorate General of Medical Education, Dhaka].

    • Talks & Publications

  • Ghosh DD, Chowdhury R R, Dutta R, Mukhopadhyay I, Mukhopadhyay A, Roychoudhury S. In-silico analysis of TCGA data showing multiple POLE-like favourable subgroups overlapping with TP53 mutated endometrial cancer: Implications for clinical practice in low and middle-income countries. https://doi.org/10.1016/j.gore.2023.101209.
  • Mandal P, Bhattacharjee B, Sen S, Bhattacharya A, Saha SS, Chowdhury RR, Mondal NR, Chakrabarty B, Chatterjee T, Roy S, Sengupta S. Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes. Transl Oncol. 2021 Oct 27;15(1):101256. doi: 10.1016/j.tranon.2021.101256. Epub ahead of print. PMID: 34717279; PMCID: PMC8564679.
  • Kurtz JE, Gebski V, Sukhin V, Carey M, Kong I, Glasspool RM, Berek JS, de Paiva Batista M, Hall M, Kim JW, Yeoshoua E, Fujiwara N, Nam BH, Polleis S, Lee JY, Strojna A, Farrelly L, Schwameis R, Fossati R, Darlington AS, Lai CH, Wright AA, Rosenblat O, Harter P, Roxburgh P, Chowdhury RR, Chang TC, Paoletti X, Friedlander M; Gynecologic Cancer InterGroup (GCIG) symptom benefit committee. Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee. Gynecol Oncol. 2021 May;161(2):502-507. doi: 10.1016/j.ygyno.2021.02.018. Epub 2021 Feb 19. PMID: 33612336.
  • Mukhopadhyay A, Ghosh T, Bhattacharjee D, Chakraborty D, Gupta , Roychowdhury I, Chatterjee P, Vemekar M, Chowdhury RR, Intermittent PARP Inhibitor Regimen In Ovarian Cancer (IPIROC): Origin and Feasibility Of Implementing A Proof –Of –Concept Exploratory Study.18 October 2023 IGCS Abstracts.

    Languages Spoken

  • English
  • Bengali
  • Hindi

    • Overview

  • Dr. Rahul Roy Chowdhury is a highly experienced Consultant in Gynaecology and Gynaecological Oncology at Manipal Hospitals, Saltlake, Kolkata. With 33 years of distinguished experience, including 19 years as a specialist, he is widely recognised for his unparalleled expertise in the field of Gynaecological Oncology.

  • He completed his MBBS from the University of Calcutta before moving to the United Kingdom, where he spent a significant part of his career. There, he underwent rigorous training across several renowned institutions and earned the prestigious FRCOG qualification from the Royal College of Obstetricians and Gynaecologists, London. He also holds a Certificate of Completion of Training (CCT) from the Professional Medical Education and Training Board in the UK and is a member of the Royal College of Obstetricians and Gynaecologists (MRCOG).

  • Dr. Roy Chowdhury further specialised in Gynaecological Oncology at the esteemed Oxford Cancer Centre, at a renowned Hospital. After returning to India, he quickly established himself as one of the leading experts in the field. He is known for his exceptional proficiency in complex gynaecologic oncological surgeries, including pelvic and upper abdominal procedures, peritonectomies, and radical pelvic floor clearances for ovarian and cervical cancers. He is also skilled in laparoscopic pelvic and retroperitoneal nodal clearances for endometrial cancers, sentinel lymph node biopsies, and surgeries for vulvar cancer.

  • As a clinician-scientist, he has participated in both sponsored and investigator-initiated clinical trials, contributing to practice-changing research in advanced cervical cancer. He has also been invited as a resource faculty at a Medical College, where he trained consultants in gynaecologic oncologic surgery and conducted multidisciplinary tumour boards.

  • With his extensive experience, advanced international training, and commitment to delivering personalised, high-quality care, Dr. Roy Chowdhury is regarded as one of the foremost specialists in Gynaecological Oncology in Kolkata. Dedicated to advancing women’s health through expertise, compassion, and innovation always.

    • Fellowship & Membership

  • Fellow of the Royal College of Obstetricians and Gynaecologists, UK (FRCOG)
  • Member of the Royal College of Obstetricians and Gynaecologists, UK (MRCOG)
  • Member of the Association of Gynaecologic Oncology
  • Member of the Gynae Cancer InterGroup
  • Founding member of the Kolkata Gynecological Oncology Trials and Translational Research Group

    • Field of Expertise

  • Expertise in performing Gynaecologic Oncological Surgeries, such as Pelvic and Upper Abdominal Surgeries, Peritonectomies, and Radical Pelvic Floor Clearances in ovarian and cervical cancers, improving the lives of these patients.
  • Skilled in Minimally Invasive Laparoscopic Procedures such as Laparoscopic Pelvic and Retroperitoneal Nodal Clearances for the treatment of endometrial cancers.
  • Experienced in performing Vulvar Cancer surgeries and providing specialised care for patients.

    • Awards & Achievements

  • Local Mentor for In-Country IGCS Fellowship, India.
  • LMIC representative for the 1st Endometrial Cancer Consensus Conference for Clinical Research (ECCC-CR) on November 2nd and 3rd, 2023, in Seoul, Korea.
  • Resource person for training consultants at Chittagong Medical College, Chittagong, Bangladesh [Invited by Medical Education and Health Manpower Development, Directorate General of Medical Education, Dhaka].

    • Talks & Publications

  • Ghosh DD, Chowdhury R R, Dutta R, Mukhopadhyay I, Mukhopadhyay A, Roychoudhury S. In-silico analysis of TCGA data showing multiple POLE-like favourable subgroups overlapping with TP53 mutated endometrial cancer: Implications for clinical practice in low and middle-income countries. https://doi.org/10.1016/j.gore.2023.101209.
  • Mandal P, Bhattacharjee B, Sen S, Bhattacharya A, Saha SS, Chowdhury RR, Mondal NR, Chakrabarty B, Chatterjee T, Roy S, Sengupta S. Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes. Transl Oncol. 2021 Oct 27;15(1):101256. doi: 10.1016/j.tranon.2021.101256. Epub ahead of print. PMID: 34717279; PMCID: PMC8564679.
  • Kurtz JE, Gebski V, Sukhin V, Carey M, Kong I, Glasspool RM, Berek JS, de Paiva Batista M, Hall M, Kim JW, Yeoshoua E, Fujiwara N, Nam BH, Polleis S, Lee JY, Strojna A, Farrelly L, Schwameis R, Fossati R, Darlington AS, Lai CH, Wright AA, Rosenblat O, Harter P, Roxburgh P, Chowdhury RR, Chang TC, Paoletti X, Friedlander M; Gynecologic Cancer InterGroup (GCIG) symptom benefit committee. Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee. Gynecol Oncol. 2021 May;161(2):502-507. doi: 10.1016/j.ygyno.2021.02.018. Epub 2021 Feb 19. PMID: 33612336.
  • Mukhopadhyay A, Ghosh T, Bhattacharjee D, Chakraborty D, Gupta , Roychowdhury I, Chatterjee P, Vemekar M, Chowdhury RR, Intermittent PARP Inhibitor Regimen In Ovarian Cancer (IPIROC): Origin and Feasibility Of Implementing A Proof –Of –Concept Exploratory Study.18 October 2023 IGCS Abstracts.

    Field of Expertise

  • Expertise in performing Gynaecologic Oncological Surgeries, such as Pelvic and Upper Abdominal Surgeries, Peritonectomies, and Radical Pelvic Floor Clearances in ovarian and cervical cancers, improving the lives of these patients.
  • Skilled in Minimally Invasive Laparoscopic Procedures such as Laparoscopic Pelvic and Retroperitoneal Nodal Clearances for the treatment of endometrial cancers.
  • Experienced in performing Vulvar Cancer surgeries and providing specialised care for patients.

    • Fellowship & Membership

  • Fellow of the Royal College of Obstetricians and Gynaecologists, UK (FRCOG)
  • Member of the Royal College of Obstetricians and Gynaecologists, UK (MRCOG)
  • Member of the Association of Gynaecologic Oncology
  • Member of the Gynae Cancer InterGroup
  • Founding member of the Kolkata Gynecological Oncology Trials and Translational Research Group

    • Languages Spoken

  • English
  • Bengali
  • Hindi

    • Awards & Achievements

  • Local Mentor for In-Country IGCS Fellowship, India.
  • LMIC representative for the 1st Endometrial Cancer Consensus Conference for Clinical Research (ECCC-CR) on November 2nd and 3rd, 2023, in Seoul, Korea.
  • Resource person for training consultants at Chittagong Medical College, Chittagong, Bangladesh [Invited by Medical Education and Health Manpower Development, Directorate General of Medical Education, Dhaka].

    • Talks & Publications

  • Ghosh DD, Chowdhury R R, Dutta R, Mukhopadhyay I, Mukhopadhyay A, Roychoudhury S. In-silico analysis of TCGA data showing multiple POLE-like favourable subgroups overlapping with TP53 mutated endometrial cancer: Implications for clinical practice in low and middle-income countries. https://doi.org/10.1016/j.gore.2023.101209.
  • Mandal P, Bhattacharjee B, Sen S, Bhattacharya A, Saha SS, Chowdhury RR, Mondal NR, Chakrabarty B, Chatterjee T, Roy S, Sengupta S. Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes. Transl Oncol. 2021 Oct 27;15(1):101256. doi: 10.1016/j.tranon.2021.101256. Epub ahead of print. PMID: 34717279; PMCID: PMC8564679.
  • Kurtz JE, Gebski V, Sukhin V, Carey M, Kong I, Glasspool RM, Berek JS, de Paiva Batista M, Hall M, Kim JW, Yeoshoua E, Fujiwara N, Nam BH, Polleis S, Lee JY, Strojna A, Farrelly L, Schwameis R, Fossati R, Darlington AS, Lai CH, Wright AA, Rosenblat O, Harter P, Roxburgh P, Chowdhury RR, Chang TC, Paoletti X, Friedlander M; Gynecologic Cancer InterGroup (GCIG) symptom benefit committee. Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee. Gynecol Oncol. 2021 May;161(2):502-507. doi: 10.1016/j.ygyno.2021.02.018. Epub 2021 Feb 19. PMID: 33612336.
  • Mukhopadhyay A, Ghosh T, Bhattacharjee D, Chakraborty D, Gupta , Roychowdhury I, Chatterjee P, Vemekar M, Chowdhury RR, Intermittent PARP Inhibitor Regimen In Ovarian Cancer (IPIROC): Origin and Feasibility Of Implementing A Proof –Of –Concept Exploratory Study.18 October 2023 IGCS Abstracts.

    • Overview

  • Dr. Rahul Roy Chowdhury is a highly experienced Consultant in Gynaecology and Gynaecological Oncology at Manipal Hospitals, Saltlake, Kolkata. With 33 years of distinguished experience, including 19 years as a specialist, he is widely recognised for his unparalleled expertise in the field of Gynaecological Oncology.

  • He completed his MBBS from the University of Calcutta before moving to the United Kingdom, where he spent a significant part of his career. There, he underwent rigorous training across several renowned institutions and earned the prestigious FRCOG qualification from the Royal College of Obstetricians and Gynaecologists, London. He also holds a Certificate of Completion of Training (CCT) from the Professional Medical Education and Training Board in the UK and is a member of the Royal College of Obstetricians and Gynaecologists (MRCOG).

  • Dr. Roy Chowdhury further specialised in Gynaecological Oncology at the esteemed Oxford Cancer Centre, at a renowned Hospital. After returning to India, he quickly established himself as one of the leading experts in the field. He is known for his exceptional proficiency in complex gynaecologic oncological surgeries, including pelvic and upper abdominal procedures, peritonectomies, and radical pelvic floor clearances for ovarian and cervical cancers. He is also skilled in laparoscopic pelvic and retroperitoneal nodal clearances for endometrial cancers, sentinel lymph node biopsies, and surgeries for vulvar cancer.

  • As a clinician-scientist, he has participated in both sponsored and investigator-initiated clinical trials, contributing to practice-changing research in advanced cervical cancer. He has also been invited as a resource faculty at a Medical College, where he trained consultants in gynaecologic oncologic surgery and conducted multidisciplinary tumour boards.

  • With his extensive experience, advanced international training, and commitment to delivering personalised, high-quality care, Dr. Roy Chowdhury is regarded as one of the foremost specialists in Gynaecological Oncology in Kolkata. Dedicated to advancing women’s health through expertise, compassion, and innovation always.

    Awards & Achievements

  • Local Mentor for In-Country IGCS Fellowship, India.
  • LMIC representative for the 1st Endometrial Cancer Consensus Conference for Clinical Research (ECCC-CR) on November 2nd and 3rd, 2023, in Seoul, Korea.
  • Resource person for training consultants at Chittagong Medical College, Chittagong, Bangladesh [Invited by Medical Education and Health Manpower Development, Directorate General of Medical Education, Dhaka].

    • Fellowship & Membership

  • Fellow of the Royal College of Obstetricians and Gynaecologists, UK (FRCOG)
  • Member of the Royal College of Obstetricians and Gynaecologists, UK (MRCOG)
  • Member of the Association of Gynaecologic Oncology
  • Member of the Gynae Cancer InterGroup
  • Founding member of the Kolkata Gynecological Oncology Trials and Translational Research Group

    • Field of Expertise

  • Expertise in performing Gynaecologic Oncological Surgeries, such as Pelvic and Upper Abdominal Surgeries, Peritonectomies, and Radical Pelvic Floor Clearances in ovarian and cervical cancers, improving the lives of these patients.
  • Skilled in Minimally Invasive Laparoscopic Procedures such as Laparoscopic Pelvic and Retroperitoneal Nodal Clearances for the treatment of endometrial cancers.
  • Experienced in performing Vulvar Cancer surgeries and providing specialised care for patients.

    • Languages Spoken

  • English
  • Bengali
  • Hindi

    • Talks & Publications

  • Ghosh DD, Chowdhury R R, Dutta R, Mukhopadhyay I, Mukhopadhyay A, Roychoudhury S. In-silico analysis of TCGA data showing multiple POLE-like favourable subgroups overlapping with TP53 mutated endometrial cancer: Implications for clinical practice in low and middle-income countries. https://doi.org/10.1016/j.gore.2023.101209.
  • Mandal P, Bhattacharjee B, Sen S, Bhattacharya A, Saha SS, Chowdhury RR, Mondal NR, Chakrabarty B, Chatterjee T, Roy S, Sengupta S. Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes. Transl Oncol. 2021 Oct 27;15(1):101256. doi: 10.1016/j.tranon.2021.101256. Epub ahead of print. PMID: 34717279; PMCID: PMC8564679.
  • Kurtz JE, Gebski V, Sukhin V, Carey M, Kong I, Glasspool RM, Berek JS, de Paiva Batista M, Hall M, Kim JW, Yeoshoua E, Fujiwara N, Nam BH, Polleis S, Lee JY, Strojna A, Farrelly L, Schwameis R, Fossati R, Darlington AS, Lai CH, Wright AA, Rosenblat O, Harter P, Roxburgh P, Chowdhury RR, Chang TC, Paoletti X, Friedlander M; Gynecologic Cancer InterGroup (GCIG) symptom benefit committee. Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee. Gynecol Oncol. 2021 May;161(2):502-507. doi: 10.1016/j.ygyno.2021.02.018. Epub 2021 Feb 19. PMID: 33612336.
  • Mukhopadhyay A, Ghosh T, Bhattacharjee D, Chakraborty D, Gupta , Roychowdhury I, Chatterjee P, Vemekar M, Chowdhury RR, Intermittent PARP Inhibitor Regimen In Ovarian Cancer (IPIROC): Origin and Feasibility Of Implementing A Proof –Of –Concept Exploratory Study.18 October 2023 IGCS Abstracts.

    • Overview

  • Dr. Rahul Roy Chowdhury is a highly experienced Consultant in Gynaecology and Gynaecological Oncology at Manipal Hospitals, Saltlake, Kolkata. With 33 years of distinguished experience, including 19 years as a specialist, he is widely recognised for his unparalleled expertise in the field of Gynaecological Oncology.

  • He completed his MBBS from the University of Calcutta before moving to the United Kingdom, where he spent a significant part of his career. There, he underwent rigorous training across several renowned institutions and earned the prestigious FRCOG qualification from the Royal College of Obstetricians and Gynaecologists, London. He also holds a Certificate of Completion of Training (CCT) from the Professional Medical Education and Training Board in the UK and is a member of the Royal College of Obstetricians and Gynaecologists (MRCOG).

  • Dr. Roy Chowdhury further specialised in Gynaecological Oncology at the esteemed Oxford Cancer Centre, at a renowned Hospital. After returning to India, he quickly established himself as one of the leading experts in the field. He is known for his exceptional proficiency in complex gynaecologic oncological surgeries, including pelvic and upper abdominal procedures, peritonectomies, and radical pelvic floor clearances for ovarian and cervical cancers. He is also skilled in laparoscopic pelvic and retroperitoneal nodal clearances for endometrial cancers, sentinel lymph node biopsies, and surgeries for vulvar cancer.

  • As a clinician-scientist, he has participated in both sponsored and investigator-initiated clinical trials, contributing to practice-changing research in advanced cervical cancer. He has also been invited as a resource faculty at a Medical College, where he trained consultants in gynaecologic oncologic surgery and conducted multidisciplinary tumour boards.

  • With his extensive experience, advanced international training, and commitment to delivering personalised, high-quality care, Dr. Roy Chowdhury is regarded as one of the foremost specialists in Gynaecological Oncology in Kolkata. Dedicated to advancing women’s health through expertise, compassion, and innovation always.

    Talks & Publications

  • Ghosh DD, Chowdhury R R, Dutta R, Mukhopadhyay I, Mukhopadhyay A, Roychoudhury S. In-silico analysis of TCGA data showing multiple POLE-like favourable subgroups overlapping with TP53 mutated endometrial cancer: Implications for clinical practice in low and middle-income countries. https://doi.org/10.1016/j.gore.2023.101209.
  • Mandal P, Bhattacharjee B, Sen S, Bhattacharya A, Saha SS, Chowdhury RR, Mondal NR, Chakrabarty B, Chatterjee T, Roy S, Sengupta S. Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes. Transl Oncol. 2021 Oct 27;15(1):101256. doi: 10.1016/j.tranon.2021.101256. Epub ahead of print. PMID: 34717279; PMCID: PMC8564679.
  • Kurtz JE, Gebski V, Sukhin V, Carey M, Kong I, Glasspool RM, Berek JS, de Paiva Batista M, Hall M, Kim JW, Yeoshoua E, Fujiwara N, Nam BH, Polleis S, Lee JY, Strojna A, Farrelly L, Schwameis R, Fossati R, Darlington AS, Lai CH, Wright AA, Rosenblat O, Harter P, Roxburgh P, Chowdhury RR, Chang TC, Paoletti X, Friedlander M; Gynecologic Cancer InterGroup (GCIG) symptom benefit committee. Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee. Gynecol Oncol. 2021 May;161(2):502-507. doi: 10.1016/j.ygyno.2021.02.018. Epub 2021 Feb 19. PMID: 33612336.
  • Mukhopadhyay A, Ghosh T, Bhattacharjee D, Chakraborty D, Gupta , Roychowdhury I, Chatterjee P, Vemekar M, Chowdhury RR, Intermittent PARP Inhibitor Regimen In Ovarian Cancer (IPIROC): Origin and Feasibility Of Implementing A Proof –Of –Concept Exploratory Study.18 October 2023 IGCS Abstracts.

    • Overview

  • Dr. Rahul Roy Chowdhury is a highly experienced Consultant in Gynaecology and Gynaecological Oncology at Manipal Hospitals, Saltlake, Kolkata. With 33 years of distinguished experience, including 19 years as a specialist, he is widely recognised for his unparalleled expertise in the field of Gynaecological Oncology.

  • He completed his MBBS from the University of Calcutta before moving to the United Kingdom, where he spent a significant part of his career. There, he underwent rigorous training across several renowned institutions and earned the prestigious FRCOG qualification from the Royal College of Obstetricians and Gynaecologists, London. He also holds a Certificate of Completion of Training (CCT) from the Professional Medical Education and Training Board in the UK and is a member of the Royal College of Obstetricians and Gynaecologists (MRCOG).

  • Dr. Roy Chowdhury further specialised in Gynaecological Oncology at the esteemed Oxford Cancer Centre, at a renowned Hospital. After returning to India, he quickly established himself as one of the leading experts in the field. He is known for his exceptional proficiency in complex gynaecologic oncological surgeries, including pelvic and upper abdominal procedures, peritonectomies, and radical pelvic floor clearances for ovarian and cervical cancers. He is also skilled in laparoscopic pelvic and retroperitoneal nodal clearances for endometrial cancers, sentinel lymph node biopsies, and surgeries for vulvar cancer.

  • As a clinician-scientist, he has participated in both sponsored and investigator-initiated clinical trials, contributing to practice-changing research in advanced cervical cancer. He has also been invited as a resource faculty at a Medical College, where he trained consultants in gynaecologic oncologic surgery and conducted multidisciplinary tumour boards.

  • With his extensive experience, advanced international training, and commitment to delivering personalised, high-quality care, Dr. Roy Chowdhury is regarded as one of the foremost specialists in Gynaecological Oncology in Kolkata. Dedicated to advancing women’s health through expertise, compassion, and innovation always.

    • Fellowship & Membership

  • Fellow of the Royal College of Obstetricians and Gynaecologists, UK (FRCOG)
  • Member of the Royal College of Obstetricians and Gynaecologists, UK (MRCOG)
  • Member of the Association of Gynaecologic Oncology
  • Member of the Gynae Cancer InterGroup
  • Founding member of the Kolkata Gynecological Oncology Trials and Translational Research Group

    • Field of Expertise

  • Expertise in performing Gynaecologic Oncological Surgeries, such as Pelvic and Upper Abdominal Surgeries, Peritonectomies, and Radical Pelvic Floor Clearances in ovarian and cervical cancers, improving the lives of these patients.
  • Skilled in Minimally Invasive Laparoscopic Procedures such as Laparoscopic Pelvic and Retroperitoneal Nodal Clearances for the treatment of endometrial cancers.
  • Experienced in performing Vulvar Cancer surgeries and providing specialised care for patients.

    • Languages Spoken

  • English
  • Bengali
  • Hindi

    • Awards & Achievements

  • Local Mentor for In-Country IGCS Fellowship, India.
  • LMIC representative for the 1st Endometrial Cancer Consensus Conference for Clinical Research (ECCC-CR) on November 2nd and 3rd, 2023, in Seoul, Korea.
  • Resource person for training consultants at Chittagong Medical College, Chittagong, Bangladesh [Invited by Medical Education and Health Manpower Development, Directorate General of Medical Education, Dhaka].

FAQ's

Patients visit Dr. Rahul Roy Chowdhury, a leading Consultant - Gynaecological Oncology Specialist at Manipal Hospitals Salt Lake - Kolkata, for expert care and advanced treatments. Known for accurate diagnoses and patient centric care, Dr. Rahul Roy Chowdhury is a trusted choice for exceptional medical support.

Home Saltlake Doctors Dr-rahul-roy-chowdhury-gynecologic-oncologist

Appointment
Health Check
Home Care
Contact Us
review icon
Review Us
Call Us